Clinical Trial Update: Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia. [Phase 3]

View source ↗

Summary

Phase 3 trial update notes completion and posted results for Prospekta in treating post-acute COVID-19 syndrome (post-COVID-19 asthenia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Prospekta

Snippet

Sponsor: Materia Medica Holding | Conditions: Post-acute COVID-19 Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-09-23